We applied the Everyday Cognition (ECog) scale in normal aging adults and patients with Alzheimer’s disease (AD) to investigate associations between neuropsychological tests and neuroimaging markers.

Researchers from the CEU Cardenal Herrera University (CEU UCH), the CSIC Institute of Biomedicine and the IIS-La Fe Health Research Institute, who belong to the DeCo MICOF-CEU Department for the study ...

(HealthDay)—For older adults, the Anticholinergic Cognitive Burden Scale (ACB) shows good dose-response relationships between anticholinergic burden and adverse outcomes, according to a study ...

Artificial intelligence has become embedded into everyone’s everyday processes. From social media feeds to automation in the workplace, data is continually being analyzed, decisions made and actions ...

Cognitive impairment is a frequent and clinically relevant non-motor manifestation of Parkinson’s disease (PD), with a substantial impact on quality of life, caregiver burden, and healthcare costs 1,2 ...

Showing that an experimental Alzheimer’s therapy delivers meaningful cognitive change is hard enough. But increasingly, AD drug sponsors face an additional challenge: making sure the tests capturing ...